Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fars K Alanazi

Showing results (1-10 of 109) with videos related to

Pageof 11
Sort By:
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|December 25, 2015
The beneficial roles of Lupineus luteus and lifestyle changes in management of metabolic syndrome: A case studyGamaleldin I Harisa, Fars K Alanazi
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|January 7, 2015
Low density lipoprotein bionanoparticles: From cholesterol transport to delivery of anti-cancer drugsGamaleldin I Harisa, Fars K Alanazi
Drug Development and Industrial Pharmacy|September 30, 2008
Preparation and characterization of spironolactone-loaded gelucire microparticles using spray-drying techniqueAlaa Edeen B Yassin, Fars K Alanazi, Mahmoud El-Badry, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|February 5, 2017
Development of oral solid self-emulsifying lipid formulations of risperidone with improved in vitro dissolution and digestionMohsin Kazi, Hassan Al-Qarni, Fars K Alanazi
Plos One|May 25, 2023
Design and synthesis of multi-functional small-molecule based inhibitors of amyloid-β aggregation: Molecular modeling and in vitro evaluationAwwad A Radwan, Fars K Alanazi, Mohammad Raish
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|August 21, 2013
Designing an extended release waxy matrix tablet containing nicardipine-hydroxy propyl β cyclodextrin complexHind Al-Zein, Khalil Sakeer, Fars K Alanazi
Acta Poloniae Pharmaceutica|November 4, 2014
Rapid and sensitive bioanalytical stability-indicating method for quantification of talinolol, a selective β1 adrenoceptor antagonist in lipid based formulations using ultrafast UHPLC systemsKazi Mohsin, Safar Al-Qahtani, Fars K Alanazi
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|April 11, 2020
Design and encapsulation of anticancer dual HSP27 and HER2 inhibitor into low density lipoprotein to target ovarian cancer cellsLaila J Alhadad, Gamaleldin I Harisa, Fars K Alanazi
Current Drug Delivery|May 15, 2023
The Chimera of TPGS and Nanoscale Lipid Carriers as Lymphatic Drug Delivery Vehicles to Fight Metastatic CancersAbdelrahman Y Sherif, Gamaleldin I Harisa, Fars K Alanazi
Archives of Pharmacal Research|September 4, 2012
Erythrocyte-mediated delivery of pravastatin: in vitro study of effect of hypotonic lysis on biochemical parameters and loading efficiencyGamaleldin I Harisa, Mohamed F Ibrahim, Fars K Alanazi
Pageof 11

Showing results (1-10 of 109) with videos related to

Sort By:
Pageof 11
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|December 25, 2015
The beneficial roles of Lupineus luteus and lifestyle changes in management of metabolic syndrome: A case studyGamaleldin I Harisa, Fars K Alanazi
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|January 7, 2015
Low density lipoprotein bionanoparticles: From cholesterol transport to delivery of anti-cancer drugsGamaleldin I Harisa, Fars K Alanazi
Drug Development and Industrial Pharmacy|September 30, 2008
Preparation and characterization of spironolactone-loaded gelucire microparticles using spray-drying techniqueAlaa Edeen B Yassin, Fars K Alanazi, Mahmoud El-Badry, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|February 5, 2017
Development of oral solid self-emulsifying lipid formulations of risperidone with improved in vitro dissolution and digestionMohsin Kazi, Hassan Al-Qarni, Fars K Alanazi
Plos One|May 25, 2023
Design and synthesis of multi-functional small-molecule based inhibitors of amyloid-β aggregation: Molecular modeling and in vitro evaluationAwwad A Radwan, Fars K Alanazi, Mohammad Raish
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|August 21, 2013
Designing an extended release waxy matrix tablet containing nicardipine-hydroxy propyl β cyclodextrin complexHind Al-Zein, Khalil Sakeer, Fars K Alanazi
Acta Poloniae Pharmaceutica|November 4, 2014
Rapid and sensitive bioanalytical stability-indicating method for quantification of talinolol, a selective β1 adrenoceptor antagonist in lipid based formulations using ultrafast UHPLC systemsKazi Mohsin, Safar Al-Qahtani, Fars K Alanazi
Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society|April 11, 2020
Design and encapsulation of anticancer dual HSP27 and HER2 inhibitor into low density lipoprotein to target ovarian cancer cellsLaila J Alhadad, Gamaleldin I Harisa, Fars K Alanazi
Current Drug Delivery|May 15, 2023
The Chimera of TPGS and Nanoscale Lipid Carriers as Lymphatic Drug Delivery Vehicles to Fight Metastatic CancersAbdelrahman Y Sherif, Gamaleldin I Harisa, Fars K Alanazi
Archives of Pharmacal Research|September 4, 2012
Erythrocyte-mediated delivery of pravastatin: in vitro study of effect of hypotonic lysis on biochemical parameters and loading efficiencyGamaleldin I Harisa, Mohamed F Ibrahim, Fars K Alanazi
Pageof 11